Trodelvy is the first anti-Trop-2 ADC recently approved by the FDA for the treatment of adult patients with metastatic triple-negative breast cancer who have received at least two prior therapies for metastatic disease
Dova recently entered into a merger agreement with Swedish Orphan Biovitrum AB (Sobi)
McKesson Corporation announced a multi-year strategic growth initiative in 2018, focused on creating innovative new solutions that improve patient care delivery and drive incremental profit growth. The initiative comprises multiple growth pillars, and includes a comprehensive review of the company’s operations and cost structure, designed to increase efficiency, accelerate execution and improve long-term performance. McKesson’s […]
This is an example of a pharmaceutical company helping another group of healthcare stakeholders, health plans, because of an issue with health systems increasing cost of care. Stakeholders in the healthcare market, while working to reduce the cost of care, are trying to determine the best path to profitability. An example is Genentech’s decision to […]
McKesson Specialty Health launched its enhanced Third Party Logistics (3PL) services, which now offer even more robust, comprehensive support to pharmaceutical, biologic and medical surgical manufacturers. Customized to each customer’s needs and products, these order-to-cash and billback 3PL services encompass every step of supply chain management so patients can get the critical therapies they need. […]